NEWSLETTER 1 MARCH Produced by CSO-MOH IL
|
|
- Juniper Montgomery
- 5 years ago
- Views:
Transcription
1 Produced by CSO-MOH IL Contact: The JPIAMR secretariat is hosted by the Swedish Research Council in Stockholm, Sweden and currently involves the following staff: Ana Beramendi Jenny Fernebro Anna Vallstedt Haeger Pontus Holm Cecilia Mattsson Mikaela Laine You are welcome to contact the secretariat in any matter concerning JPIAMR using the following address: Or: JPIAMR Newsletter No.1 March 1
2 From the Chairman s Desk Mats Ulfendahl Chair, JPIAMR Management Board Secretary-General, Swedish Research Council The European Union aims at creating a unified research area, in which researchers, scientific knowledge and technology will circulate freely. The European Research Area (ERA) is expected to strengthen the scientific and technological bases in the Member States, thus enhancing their capacity to jointly address grand societal challenges. In order to support the implementation of the ERA, the European Commission introduced in 2008 the Joint Programming (JP) concept. The overall objective is to pool national research efforts in order to more effectively tackle specific challenges. In 2010 representatives of several European nations started to discuss a Joint Programming Initiative focusing on antimicrobial resistance, a rapidly emerging threat to human health. After positive Council conclusions in December 2011 the Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, was formally established. JPIAMR now includes 18 member states, and two nations follow our activities as observers. A key element in the JP concept is to establish a common view on the problems within the field, and the ways to address them, formulated in a common Strategic Research Agenda (SRA). Based on the SRA, Member States are expected commit to joint activities. In 2012 JPIAMR applied for and was granted a Coordination and Support Action, i.e. three-year funding from the European Commission to develop and implement an SRA. In other words, we are about to adopt a common view on the problems related to antimicrobial resistance, and more importantly, reach an agreement on what research efforts are required to address the problems. JPIAMR Newsletter No.1 March 2
3 A solid SRA that is recognized by the scientific community and that can be adopted by the member states is fundamental. In order to focus on the most relevant questions and to ensure scientific credibility, a Scientific Advisory Board (SAB) consisting of distinguished and prominent experts in the field, was appointed. Chaired by Professor Herman Goossens, the SAB will assist the Management Board of JPIAMR in formulating the SRA. During the next few months drafts of the SRA will be presented in order to get feedback from not only the member states but also important stakeholder organisations. A Stakeholder Advisory Board is now being established in order to facilitate this important part of the SRA process. Towards the end of the year the SRA should be finalized and then officially launched early The crucial step is of course to implement the SRA, i.e. to initiate concerted joint actions or to coordinate national programmes. This will be a challenge itself but as there is a very strong commitment among the member states I am quite optimistic about the outcome and convinced that JPIAMR will contribute to the implementation of the ERA. The Joint Programming Initiative on Antimicrobial Resistance officially started in September This collaboration currently involves 18 countries and has a main secretariat hosted by the Swedish Research Council in Stockholm, Sweden. The concept of Joint Programming (JP) was launched by the EU Commission in 2008 with the aim to increase the value of national and EU research funding by joint planning, implementation and evaluation of national research programs. Member states were invited to identify suitable themes and in the beginning of 2010 the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) was proposed by Sweden and Italy. JPIAMR Newsletter No.1 March 3
4 Antimicrobial resistance Antimicrobial resistance is a topic that clearly matches the prerequisites for a Joint Programming (JP). It is a global problem that concerns all and even though it is often described as an emerging threat it is in fact already upon us. Currently, European research on antimicrobial resistance is dispersed and with little collaboration between member states and associated countries. As shown by a recent mapping exercise, few countries appear to have a program addressing antimicrobial resistance; rather, countries are financing separate projects that have been selected in competition with projects from other research areas. The aim of the JPIAMR is to integrate relevant scientific fields across national borders and to create a common European research agenda with a shared common vision. The need for this initiative is obvious bacteria and other infecting agents know no borders and therefore transnational cooperation is crucial. Joint actions are desperately needed and JPIAMR provides the forum and platform for initiating and coordinating these actions. The participating countries are dedicated to the programme of activities, showing a great commitment to the success of the initiative. Together they have formed the first seed of a joint vision on how to combat antimicrobial resistance. JPIAMR Newsletter No.1 March 4
5 Organization The governance structure of JPIAMR includes a Management Board, a Steering Committee, a Scientific Advisory Board, a Stakeholders Advisory Board and a Secretariat. The Management Board (MB) is the main decision making body of JPIAMR, working according to the Terms of Reference. The MB meets on a regular basis and has met seven times since December Each participating country may nominate up to two members of the MB. The MB members must have a Governmental mandate and only one representative from each country may vote. The vision The JPIAMR will coordinate the best European research resources and capabilities to form the critical mass for the development of the most advanced scientific approaches to tackle the problem of antimicrobial resistance, leading to the sustainable use of antibiotics and treatments for infectious diseases. JPIAMR will therefore: Find routes for novel antibiotics and new antiinfectious strategies Scientifically validate means to increase the number of patients treated early with the appropriate antimicrobial Provide scientific evidence on ways to reduce the spread of resistant strains Provide scientific evidence on strategies to reduce the number of patients with resistant or MDR strains, at any level of antibiotic consumption Reduce the consumption of antibiotics The mission The mission of the JPI AMR is to develop scientific proposals for a sustainable use of antibiotics to treat infectious diseases in Europe, and for a decrease in the number of patients with resistant infections. An important element of the mission of JPI AMR will be to connect and collaborate with the different stakeholders involved in its mission. JPIAMR Newsletter No.1 March 5
6 Strategic research agenda (SRA) JPI AMR will define a Strategic Research Agenda with three scientific areas: Biology and dynamics of resistance Prevention of resistance and innovation of treatment options Epidemiology and disease burden The SRA will be the foundation of JPIAMR as it represents the basis upon which the JPI will launch joint actions. As a first step in the development of the SRA, a workshop was held in May 2011 to identify the major needs and challenges from a scientific perspective. The SRA is expected to be finalized in late or early 2014, but will require regular updates to ensure it remains relevant and truly strategic. The Scientific Advisory Board (SAB) Antoine Andremont Fernando Baquero Marc Bonten Yehuda Carmeli Niels Frimodt-Møller Herman Goossens Hajo Grundmann Stephan Harbarth Birgitta Henriques Normark Patrice Nordmann Arnfinn Sundsfjord Timothy Walsh Paul Williams Bruno Gonzalez-Zorn Bichat-Claude Bernard Hospital, Paris IRYCIS, Madrid UMC Utrecht, div. Julius Centrum Harvard University, Boston Statens Serum Institut, Copenhagen University of Antwerp RIVM, Bilthoven Hôpitaux Universitaires de Genèva Karolinska Institutet, Stockholm Hôspital de Bicêtre, Paris University of Tromsø Cardiff University University of Nottingham Complutense University, Madrid France Spain Netherlands United States Denmark Belgium Netherlands Switzerland Sweden France Norway United Kingdom United Kingdom Spain JPIAMR Newsletter No.1 March 6
7 Scientific Advisory Board Meeting, January 21, By Jolien Wenink, Programme Officer, ZonMw The primary task of the Scientific Advisory Board is to provide input for the development of the JPI AMR Strategic Research Agenda (SRA) and to propose scientific content and strategic directions to the JPI AMR Management Board. The foundations of the SRA have been articulated in a Vision Paper, which was endorsed in 2011 by all partners of the JPI AMR. In its deliberations, the Scientific Advisory Board considers the entire spectrum of research activity, from basic discovery to strategically targeted research, and including societal needs. It selected six research priorities and prepared a preliminary paper elaborating the selected topics. Even though, since its inception, JPI AMR has focused on human medicine, the Management Board and the Scientific Advisory Board recognize the importance of the veterinary and environmental dimensions of antimicrobial resistance. For this reason, a new member, Prof. Bruno Gonzalez-Zorn, a specialist in veterinary AMR, was asked to join to the Board. There were two major objectives to the meeting. These were to analyse and discuss the current versions of the priority topics by inviting two external experts, Prof. Jürgen Heeseman and Em. Prof Jos van der Meer, to take part in the proceedings, and secondly to discuss how veterinary perspectives can be incorporated into the existing priorities, or if they require revision to incorporate veterinary medicine into the SRA. Based on the deliberations and recommendations offered at the meeting, the members of the Scientific Advisory Board will revise and enhance the research priority paper and will prepare a preliminary draft of the SRA. This will be discussed with the Management Board, the Stakeholder Advisory Board and select experts at a conference scheduled to be held at the end of May. In September, the final draft of the SRA will be presented for web-based national consultations. The next meeting of the Scientific Advisory Board will be held on May 14,. JPIAMR Newsletter No.1 March 7
8 Invitational Conference on the JPIAMR Strategic Research Agenda By Jolien Wenink, Programme Officer, ZonMw is an important year for the JPI AMR. It is anticipated that by the end of the year, JPI AMR partners will consolidate a durable Strategic Research Agenda (SRA) on antimicrobial resistance. The Scientific Advisory Board plays an important role in the development of the JPI AMR SRA, but it requires input from the JPI AMR Management Board and the Stakeholder Advisory Board to complete the final agenda. For this reason, the content and current status of the SRA is a recurring item on the agenda of the Management Board and subsequently, Stakeholder Advisory Board meetings. Before a final draft of the SRA can be submitted for web-based, national consultations (scheduled for September ), it needs to be challenged, discussed and refined by all the relevant experts from the JPI AMR. By the end of May, the Scientific Advisory Board is scheduled to have a preliminary draft of the SRA, ready for deliberation by the members of the Scientific Advisory Board, the Management Board, the Stakeholder Advisory Board and selected guest experts at an invitational conference, to be held on May 27-28, in Geneva. The meeting will be organized in collaboration with the World Health Organization (WHO). MEMBER STATES JPIAMR Newsletter No.1 March 8
Antimicrobial Resistance, yes we care! The European Joint Action
Antimicrobial Resistance, yes we care! The European Joint Action Context of the Joint Action General objectives Inclusive governance Conclusion Context of the Joint Action 1. Context of this Joint Action
More informationOIE Platform on Animal Welfare for Europe
OIE Platform on Animal Welfare for Europe 26 th Conference of the OIE Regional Commission for Europe Bern, Switzerland, 22-26 September 2014 Dr. Stanislav RALCHEV OIE SRR Brussels Measure the progress
More informationDevelopment and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics
Priority Topic B Diagnostics Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics The overarching goal of this priority topic is to stimulate the design,
More informationThe European AMR Challenge - strategic views from the human perspective -
The European AMR Challenge - strategic views from the human perspective - World Health Organization Regional Office for Europe Dr Danilo Lo Fo Wong Senior Adviser on Antimicrobial Resistance Division of
More informationOIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)
OIE Regional Commission for Europe Regional Work Plan Framework 2017-2020 Version adopted during the 85 th OIE General Session (Paris, May 2017) Chapter 1 - Regional Directions 1.1. Introduction The slogan
More informationOIE Standards on Animal Welfare, and Capacity Building Tools and Activities to Support their Implementation
OIE Standards on Animal Welfare, and Capacity Building Tools and Activities to Support their Implementation Workshop on animal welfare Organized by EC/TAIEX in co-operation with the RSPCA and State Veterinary
More informationManaging AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan
Managing AMR at the Human-Animal Interface OIE Contributions to the AMR Global Action Plan 6th Asia-Pacific Workshop on Multi-Sectoral Collaboration for the Prevention and Control of Zoonoses Dr Susan
More informationCouncil of the European Union Brussels, 13 June 2016 (OR. en)
Council of the European Union Brussels, 13 June 2016 (OR. en) 9952/16 SAN 241 AGRI 312 VETER 58 NOTE From: To: General Secretariat of the Council Council No. prev. doc.: 9485/16 SAN 220 AGRI 296 VETER
More informationEU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play
EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play Rosa M. Peran i Sala Policy Officer AMR Coordination EC Action Plan against AMR Animal Health Advisory Committee
More informationGHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden
GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr Anders Tegnell, Ministry of Health and Social Affairs, Sweden One Health One World Increasing antibiotic resistance Antibiotic use and
More informationCanada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017
Canada s Activities in Combatting Antimicrobial Resistance Presentation to the JPIAMR Management Board March 29, 2017 AMR in Canada Surveillance data indicates that rates of infection for some resistant
More informationWHO global and regional activities on AMR and collaboration with partner organisations
WHO global and regional activities on AMR and collaboration with partner organisations Dr Danilo Lo Fo Wong Programme Manager for Control of Antimicrobial Resistance Building the AMR momentum 2011 WHO/Europe
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health and food audits and analysis REFERENCES: ECDC, MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; 2017 DG(SANTE)/2017-6248 EXECUTIVE SUMMARY
More informationStrategy 2020 Final Report March 2017
Strategy 2020 Final Report March 2017 THE COLLEGE OF VETERINARIANS OF ONTARIO Introduction This document outlines the current strategic platform of the College of Veterinarians of Ontario for the period
More informationTable Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8
Table Of Content Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8 Conference... 8 Coordinator, Leader contact and partners... 9 Outputs... 10 Final report...
More informationWORLD ORGANIZATION FOR ANIMAL HEALTH /OIE/- ENGAGEMENT WITH ANIMAL WELFARE AND THE VETERINARY PROFFESSION
WORLD ORGANIZATION FOR ANIMAL HEALTH /OIE/- ENGAGEMENT WITH ANIMAL WELFARE AND THE VETERINARY PROFFESSION Prof. Dr. Nikola Belev Honorary President OIE Regional Commission for Europe Regional Representative
More informationGlobal Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat
Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat EMA Working Parties with Patients and Consumers Organisations (PCWP) and Healthcare Professionals
More informationEuropean Goose Management Platform (EuroGMP)
European Goose Management Platform () Jesper Madsen Chair, WI Waterbird Harvest Specialist Group, Aarhus University, Denmark Sergey Dereliev AEWA Technical Officer Not the first time that geese are on
More informationContents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department
Contents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department Regional Seminar for National Focal Points for Veterinary Products, Maputo, 3 5 December 2013
More informationANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU
ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU Health and Food Safety John Paget (NIVEL) Dominique Lescure (NIVEL) Ann Versporten (University of Antwerp)
More informationOIE mission in the framework of One Health Focus on antimicrobial resistance (AMR)
Dr Rachid Bouguedour OIE Representative for North Africa OIE mission in the framework of One Health Focus on antimicrobial resistance (AMR) General Assembly of REEV-Med Hammamet, Tunisia 13 December 2017
More informationTHE MICROBIAL CHALLENGE AN EMERGING THREAT TO HUMAN / ANIMAL HEALTH
Report on the official launch of the JPIAMR Strategic Research Agenda Towards a Global Research Agenda for AMR Brussels, 3 April 2014 THE MICROBIAL CHALLENGE AN EMERGING THREAT TO HUMAN / ANIMAL HEALTH
More informationSECOND REPORT FROM THE COMMISSION TO THE COUNCIL
SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN
More informationTntibiotic resistance is a growing problem and the main cause of this problem is misuse
AIHA Internet Resources Digest Supporting Access to High Quality Online Resources June 2015 Spotlight on: Resources on Rational Antibiotic Use Tntibiotic resistance is a growing problem and the main cause
More informationGlobal action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR) Challenges on the global and regional levels Zsuzsanna Jakab WHO Regional Director for Europe 13 November support the WHO 2014, global action
More informationEuropean Medicines Agency role and experience on antimicrobial resistance
European Medicines Agency role and experience on antimicrobial resistance Regional Training Workshop on Antimicrobial Resistance (AMR) Responding to the global challenge of AMR threats: toward a one health
More informationAntimicrobial Stewardship: The South African Perspective
Antimicrobial Stewardship: The South African Perspective Precious Matsoso Director General; National Department of Health; South Africa 13 th November 2015 Why do we need an AMR strategy and implementation
More informationInternational Harmonisation in the Field of Pharmacovigilance from an OIE perspective
Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products BP 90203-35302 FOUGERES CEDEX, FRANCE elisabeth.begon@anses.fr International Harmonisation in the Field of Pharmacovigilance from an
More informationPromoting One Health : the international perspective OIE
Promoting One Health : the international perspective OIE Integrating Animal Health & Public Health: Antimicrobial Resistance SADC SPS Training Workshop (Animal Health) 29-31 January 2014 Gaborone, Botwana
More informationNational Action Plan development support tools
National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan
More informationWorld Health Organization Emerging and other Communicable Diseases, Surveillance and Control
WHO/EMC/BAC/98.6 Antimicrobial Resistance Monitoring: Update of Activities 1997/1998 World Health Organization Emerging and other Communicable Diseases, Surveillance and Control This document has been
More informationWorld Veterinary Association
World Veterinary Association Since 1863 Representing the Global Veterinary Profession WVA s Experience and Supportive Tools to promote Prudent Use of Antimicrobials Worldwide Dr Zeev NOGA Deputy Executive
More informationCommittee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018
7 December 2017 Committee for Medicinal Products for Veterinary Use (CVMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018 Chairpersons Chair: D. Murphy Status Adopted in December
More informationOIE Platform on Animal Welfare for Europe Regional Information Seminar for Recently Appointed OIE Delegates Brussels, Belgium, February 2014
OIE Platform on Animal Welfare for Europe Regional Information Seminar for Recently Appointed OIE Delegates Brussels, Belgium, 18-20 February 2014 Dr. Stanislav RALCHEV OIE Sub-Regional Representation
More informationAntimicrobial resistance I: Situation and strategies in Europe
Antimicrobial resistance I: Situation and strategies in Europe Global Past, Present and Future Challenges in Risk Assessment Strengthening Consumer Health Protection Berlin, November 30th December 1st,
More informationThe Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach
The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach Prese ted at the Workshop o Natio al A tio Plan on Antimicrobial Resistance for Developing Countries Focusing on Resistance
More informationAll participants at the Salt Lake City confirmed strong support for the OIE assuming an international laboratory animal welfare role.
1 Purpose The purpose of this discussion paper is to assist the OIE in defining, and scoping, the unique international role it can play, in the future, in connection with laboratory animal welfare. It
More informationEU Health Priorities. Jurate Svarcaite Secretary General PGEU
EU Health Priorities Jurate Svarcaite Secretary General PGEU Members: Professional Bodies & Pharmacists Associations 2016: 33 Countries Austria Belgium Bulgaria Croatia Cyprus Czech Rep Denmark Estonia
More information2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October Brussels
2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October 2018 - Brussels Aurélien PEREZ, DG Health and Food Safety Political context European level e.g. September
More informationEuropean Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE. 6 December 2011
European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE 6 December 2011 Address requests about publications of the WHO Regional Office for Europe to: Publications
More informationStrengthening capacity for the implementation of One Health in Viet Nam, Phase 2 (SCOH2) TERMS OF REFERENCE
TERMS OF REFERENCE Job Title: National consultant: Lead Researcher and Human Rabies expert: Case study on human rabies prevention in Bac Giang province of Viet Nam, and recommendations to ensure achievement
More informationOIE PVS Pathway including Veterinary Education
OIE PVS Pathway including Veterinary Education OIE Global Conference on the Prudent Use of Antimicrobial Agents for Animals: International Solidarity to Fight against Antimicrobial Resistance Paris (France)
More informationQuestions and Answers on the Community Animal Health Policy
MEMO/07/365 Brussels, 19 September 2007 Questions and Answers on the Community Animal Health Policy 2007-13 Why has the Commission developed a new Community Animal Health Policy (CAHP)? The EU plays a
More informationEU strategy to fight against Antimicrobial Resistance
EU strategy to fight against Antimicrobial Resistance OECD workshop on the Economics of Antimicrobial Use in the Livestock Sector and Development of Antimicrobial Resistance Paris, 12 October 2015 Martial
More informationMIDDLE EAST REGIONAL ANIMAL WELFARE STRATEGY
MIDDLE EAST REGIONAL ANIMAL WELFARE STRATEGY (2014-2019) Endorsed by the OIE Regional Commission for the Middle East at the OIE 82 General Session, Mai 2014 Background Animal welfare was first identified
More informationGOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY
GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY Regional Information Seminar for Recently Appointed OIE Delegates 18 20 February 2014, Brussels, Belgium Dr Mara Gonzalez 1 OIE Regional Activities
More informationOIE Strategy for Veterinary Products and Terms of Reference for the OIE National Focal Points
OIE Strategy for Veterinary Products and Terms of Reference for the OIE National Focal Points Dr Elisabeth Erlacher-Vindel, Deputy Head of the Scientific and Technical Department OIE Strategy for Veterinary
More informationOIE strategy on AMR and the Prudent Use of Antimicrobials
Dr. Jocelyn Mérot OIE Sub-Regional Representation for North Africa OIE strategy on AMR and the Prudent Use of Antimicrobials 14th JPC REMESA 19-20 July 2017 Naples (Italy) The OIE Strategy on AMR and the
More informationWHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,
More informationAntibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group
Antibiotics and resistance in the WHO Regional Office for Europe Dr Nienke van de Sande On behalf of the AMR Working Group Strengthening the fight against antimicrobial Antimicrobial APRES resistance Symposium
More informationPan-Canadian Action Plan on Antimicrobial Resistance and Antimicrobial Use
Pan-Canadian Action Plan on Antimicrobial Resistance and Antimicrobial Use Lindsay Noad Public Health Agency of Canada (PHAC) November 29 th, 2017 Purpose To provide an update on the development of the
More informationOECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division
OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH Michele Cecchini OECD Health Division Antimicrobial Resistance is a Global Threat Modern medicine and surgery
More informationAMR situation in Europe: Strategy and vision
AMR situation in Europe: Strategy and vision Koen Van Dyck Head of Unit Bilateral International Relations Head Taskforce on AMR DG Health & Food Safety European Commission According to data from 2011,
More informationDraft ESVAC Vision and Strategy
1 2 3 7 April 2016 EMA/326299/2015 Veterinary Medicines Division 4 5 6 Draft Agreed by the ESVAC network 29 March 2016 Adopted by ESVAC 31 March 2016 Start of public consultation 7 April 2016 End of consultation
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION
More informationREPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT
1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved
More informationOIE s global commitment on fighting animal diseases
Dr Etienne Bonbon President of the Terrestrial Animal Health Commission OIE s global commitment on fighting animal diseases Animal health Room for national measures in an international perspective Oslo,
More informationVeterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013
Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013 Mario Nagtzaam, SANCO D6 Political commitments as to addressing AMR
More informationWork of Regional Representations supporting the implementation of the OIE standards on animal welfare
Work of Regional Representations supporting the implementation of the OIE standards on animal welfare Third Global Conference on Animal Welfare Kuala Lumpur, Malaysia, 6-8 November 2012 Dr. Luis Osvaldo
More informationOIE Resolution and activities related to the Global Action Plan. Regional Seminar for OIE National Focal Points for Veterinary Products 4 th Cycle
Dr Elisabeth Erlacher Vindel Deputy Head of the Scientific and Technical Departement World Organisation for Animal Health (OIE) OIE Resolution and activities related to the Global Action Plan Regional
More informationQUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS
Contribution ID: bc4cbd4d-288c-4560-ad81-59ea4ecd4d5d Date: 19/04/2017 16:02:09 QUESTIONNAIRE FOR ADMINISTRATIONS, ASSOCIATIONS AND OTHER ORGANISATIONS Public Consultation on possible activities under
More informationOverview of the OIE PVS Pathway
Overview of the OIE PVS Pathway Regional Seminar for OIE National Focal Points for Animal Production Food Safety Hanoi, Vietnam, 24-26 June 2014 Dr Agnes Poirier OIE Sub-Regional Representation for South-East
More informationAntimicrobial resistance. Summary of OIE Activities
Antimicrobial resistance Summary of OIE Activities July 2015 EDITORIAL Risks associated with the use of antimicrobials in animals worldwide Dr Vallat, Director General of the World Organisation for Animal
More information6-7 November Ministry of Health, Youth, Sport and Voluntary Sector. Pierre Laroque Amphitheater
EUROPEAN WORKSHOP PUBLIC AWARENESS CAMPAIGNS ON THE PRUDENT USE OF ANTIBIOTICS 6-7 November 2008 Ministry of Health, Youth, Sport and Voluntary Sector Pierre Laroque Amphitheater 14, avenue Duquesne, 75350
More informationBuilding Competence and Confidence. The OIE PVS Pathway
Dr. Alain Dehove (OIE) Coordinator of the World Animal Health and Welfare Fund Building Competence and Confidence The OIE PVS Pathway OIE Global Conference on Wildlife Animal Health and Biodiversity -
More informationEvaluation of EU strategy to combat AMR
Evaluation of EU strategy to combat AMR Advisory Group of the Food Chain 30 April 2015 Martial Plantady Legislative officer DDG2.G4: Food, Alert Systems & Training DG Health and Food Safety Antimicrobial
More informationCouncil Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting
COUNCIL OF THE EUROPEAN UNION Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting Luxembourg, 10 June 2008 The Council adopted
More informationPan-Canadian Framework and Approach to Antimicrobial Resistance. Presentation to the TATFAR Policy Dialogue September 27, 2017
Pan-Canadian Framework and Approach to Antimicrobial Resistance Presentation to the TATFAR Policy Dialogue September 27, 2017 PURPOSE Purpose To provide TATFAR members with an overview of Canada s coordinated
More informationOutcomes of AVSBN 2017
Outcomes of AVSBN 2017 Prof. Dr. Achariya Sailasuta, Vice President of Veterinary Council of Thailand, VCT Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University Bangkok, Thailand
More informationOIE AMR Strategy, One Health concept and Tripartite activities
Dr Mária Szabó Chargée de mission OIE AMR Strategy, One Health concept and Tripartite activities Training Seminar for Middle East Focal Points for Veterinary Products Beirut, Lebanon 2017 Summary OIE strategy
More informationWorld Organisation for Animal Health
World Organisation for Animal Health 2017 Progressive Actions for Achievement of global health security Dr Susan Corning BA MSc BVSc MRCVS FRSPH Global Health Security Agenda Steering Group Meeting Geneva,
More informationW O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p
WHO strategic action plan on antibiotic resista ance in Europe Strengthening g surveillance Dr Danilo Lo Fo Wong Senior Adv viser AMR Backg ground AMR costs money, livelihoods and lives, and undermines
More information21st Conference of the OIE Regional Commission for Europe. Avila (Spain), 28 September 1 October 2004
21st Conference of the OIE Regional Commission for Europe Avila (Spain), 28 September 1 October 2004 Recommendation No. 1: Recommendation No. 2: Recommendation No. 3: Contingency planning and simulation
More informationInternational approach for veterinary medicinal products: OIE and Codex alimentarius
Dr Catherine Lambert OIE, AFSSA/ANMV Collaborating Centre for Veterinary medicinal products BP 90203-35302 FOUGERES CEDEX, FRANCE c.lambert@anmv.afssa.fr International approach for veterinary medicinal
More informationAntimicrobial Resistance Direction Statement for Animals and Plants, and Work Programme
Antimicrobial Resistance Direction Statement for Animals and Plants, and Work Programme MPI Discussion Paper No: 2016/10 ISBN No: 978-1-77665-185-0 (online) ISSN No: 2253-3907 (online) February 2016 Disclaimer
More informationAntimicrobial Resistance Initiative
Antimicrobial Resistance Initiative Antimicrobial Resistance Initiative Resistance to antimicrobial agents has become a threat to public health all over the world. Microorganisms become resistant to antimicrobial
More informationand suitability aspects of food control. CAC and the OIE have Food safety is an issue of increasing concern world wide and
forum Cooperation between the Codex Alimentarius Commission and the OIE on food safety throughout the food chain Information Document prepared by the OIE Working Group on Animal Production Food Safety
More informationGlobal Coordination of Animal Disease Research. Alex Morrow
Global Coordination of Animal Disease Research Alex Morrow Focus of Presentation Background to STAR-IDAZ Activities and outputs/outcomes of STAR-IDAZ Priority topics Long-term research needs Plans for
More informationONE HEALTH AND THE POWER OF PLATFORMS. One Health Models for Cross-Sectoral Coordination on Zoonotic Diseases
ONE HEALTH AND THE POWER OF PLATFORMS One Health Models for Cross-Sectoral Coordination on Zoonotic Diseases OPENING REMARKS INDONESIA Dr. Fuadi Darwis, MPH Senior Advisor, Advisory Board, National Disaster
More informationAntimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016
Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016 What is Antimicrobial Stewardship? Conserving the effectiveness of existing treatments through infection prevention and
More informationThe UK strategy for antimicrobial resistance (AMR) and its implications for research and development
The UK strategy for antimicrobial resistance (AMR) and its implications for research and development John Watson Deputy Chief Medical Officer Department of Health Thursday 3 April 2014 1 The UK Antimicrobial
More informationinternational news RECOMMENDATIONS
The Third OIE Global Conference on Veterinary Education and the Role of the Veterinary Statutory Body was held in Foz do Iguaçu (Brazil) from 4 to 6 December 2013. The Conference addressed the need for
More informationOne Health Collaboration to combat Antimicrobial resistance
One Health Collaboration to combat Antimicrobial resistance Dr Awa Aidara-Kane, World Health Organization Dr Elisabeth Erlacher-Vindel, World Organization for Animal Health (OIE) Dr Patrick Otto, Food
More informationDr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health
Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health Regional Workshop for National Focal Points for Veterinary Products
More informationOIE capacity-building activities
OIE capacity-building activities OIE Regional Seminar for Recently Appointed OIE Delegates Tokyo (Japan) 7-8 February 2012 Dr Mara Gonzalez Ortiz OIE Regional Activities Department OIE Fifth Strategic
More informationGeneral presentation of the OIE
General presentation of the OIE Regional Seminar for OIE National Focal Points for Animal Production Food Safety Belgrade, Serbia, 15 17 October, 2013 Dr N. Leboucq OIE Sub-Regional Representation in Brussels
More informationAnimal Welfare: the role of the OIE
Animal Welfare: the role of the OIE Dr Sarah Kahn Director, International Trade Department Animal Welfare in Europe: Achievements and Future Prospects Strasbourg, 23-24 November 2006 CONTENTS Introduction
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationEvaluation of Performance of Veterinary Services - Viet Nam experience
Evaluation of Performance of Veterinary Services - Viet Nam experience 3 rd Coordination Conference for ZDAP Da Nang, Viet Nam, 28-30 August 2018 Dr Do Huu Dung Head, Planning Division Department of Animal
More informationQUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS
Contribution ID: eb78a906-8b33-4cbe-a9a3-d0720e7cd318 Date: 18/04/2017 18:16:34 QUESTIONNAIRE FOR ADMINISTRATIONS, ASSOCIATIONS AND OTHER ORGANISATIONS Public Consultation on possible activities under
More informationActivities for Zoonotic Diseases in Cambodia
Ministry of Agriculture, Forestry and Fisheries General Directorate of Animal Health and Production 3 rd COORDINATION CONFERENCE FOR THE ZOONOTIC DISEASES ACTION PACKAGE (ZDAP), STRENGTHENING COOPERATION
More informationSpeaking notes submitted by Dr. Duane Landals. on behalf of the Canadian Veterinary Medical Association (CVMA)
339, rue Booth Street Ottawa (Ontario) K1R 7K1 t (800) 567-2862 f (613) 236-9681 admin@cvma-acmv.org Speaking notes submitted by Dr. Duane Landals on behalf of the Canadian Veterinary Medical Association
More informationQUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS
Contribution ID: 6945a24b-2a9b-4774-af54-ad925a28f304 Date: 25/04/2017 11:02:44 QUESTIONNAIRE FOR ADMINISTRATIONS, ASSOCIATIONS AND OTHER ORGANISATIONS Public Consultation on possible activities under
More informationEFSA s activities on Antimicrobial Resistance
EFSA s activities on Antimicrobial Resistance CRL-AR, Copenhagen 23 April 2009 Annual Workshop of CRL - AR 1 Efsa s Role and Activities on AMR Scientific advices Analyses of data on AR submitted by MSs
More informationINTERNATIONAL PARTNERSHIP FOR DOGS DogWellNet.Com. Dr. Brenda Bonnett, CEO
INTERNATIONAL PARTNERSHIP FOR DOGS DogWellNet.Com Dr. Brenda Bonnett, CEO brenda.bonnett@ipfdogs.com Outline this talk this morning Background and Overview on the IPFD Tour of DogWellNet.com Presentations
More informationFirst-year experiences in implementing Thailand s National Strategic Plan on AMR
First-year experiences in implementing Thailand s National Strategic Plan on AMR 2017-2021 Dr. Nithima Sumpradit Food and Drug Administration Ministry of Public Health, Thailand Regional Workshop on AMR
More informationDr Bernard Vallat OIE Director General
OIE Policies on Veterinary Education 25 th Conference of the OIE Regional Commission for Europe Fleesensee (Germany), 17-21 September 2012 Dr Bernard Vallat OIE Director General 1 Contents Role of the
More informationPerspective on AnA Global timicrobial Resistance
National Center for Emerging and Zoonotic Infectious Diseases Perspective on AnA Global timicrobial Resistance Dawn M. Sievert, PhD, MS Associate Director for Antimicrobial Resistance Division of Foodborne,
More informationNOTIFICATION TO THE PARTIES
CONVENTION ON INTERNATIONAL TRADE IN ENDANGERED SPECIES OF WILD FAUNA AND FLORA NOTIFICATION TO THE PARTIES No. 2018/030 Geneva, 26 March 2018 CONCERNING: Implementation of Decision 17.297 on Tortoises
More informationDr René A. Carlson President, World Veterinary Association. The Current and Future Role of the WVA in Continuing Education for Veterinarians
Dr René A. Carlson President, World Veterinary Association The Current and Future Role of the WVA in Continuing Education for Veterinarians CONTENT Introduction of the World Veterinary Association WVA
More information